Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Details

Connection

Robert Griffin to Combined Modality Therapy

This is a "connection" page, showing publications Robert Griffin has written about Combined Modality Therapy.

 
Connection Strength
  
 
 
1.151
  
  1. Johnsrud AJ, Jenkins SV, Jamshidi-Parsian A, Quick CM, Galhardo EP, Dings RPM, Vang KB, Narayanasamy G, Makhoul I, Griffin RJ. Evidence for Early Stage Anti-Tumor Immunity Elicited by Spatially Fractionated Radiotherapy-Immunotherapy Combinations. Radiat Res. 2020 12 01; 194(6):688-697.
    View in: PubMed
    Score: 0.159
  2. Griffin RJ, Dings RPM, Makhoul I. Further rationale for optimal combined modality treatments. Oncotarget. 2017 04 18; 8(16):25831-25832.
    View in: PubMed
    Score: 0.124
  3. Koonce NA, Quick CM, Hardee ME, Jamshidi-Parsian A, Dent JA, Paciotti GF, Nedosekin D, Dings RP, Griffin RJ. Combination of Gold Nanoparticle-Conjugated Tumor Necrosis Factor-a and Radiation Therapy Results in a Synergistic Antitumor Response in Murine Carcinoma Models. Int J Radiat Oncol Biol Phys. 2015 Nov 01; 93(3):588-96.
    View in: PubMed
    Score: 0.110
  4. Griffin RJ, Koonce NA, Dings RP, Siegel E, Moros EG, Br?uer-Krisch E, Corry PM. Microbeam radiation therapy alters vascular architecture and tumor oxygenation and is enhanced by a galectin-1 targeted anti-angiogenic peptide. Radiat Res. 2012 Jun; 177(6):804-12.
    View in: PubMed
    Score: 0.088
  5. Przybyla BD, Shafirstein G, Koonce NA, Webber JS, Griffin RJ. Conductive thermal ablation of 4T1 murine breast carcinoma reduces severe hypoxia in surviving tumour. Int J Hyperthermia. 2012; 28(2):156-62.
    View in: PubMed
    Score: 0.086
  6. Dings RP, Loren ML, Zhang Y, Mikkelson S, Mayo KH, Corry P, Griffin RJ. Tumour thermotolerance, a physiological phenomenon involving vessel normalisation. Int J Hyperthermia. 2011; 27(1):42-52.
    View in: PubMed
    Score: 0.080
  7. Jia D, Koonce NA, Halakatti R, Li X, Yaccoby S, Swain FL, Suva LJ, Hennings L, Berridge MS, Apana SM, Mayo K, Corry PM, Griffin RJ. Repression of multiple myeloma growth and preservation of bone with combined radiotherapy and anti-angiogenic agent. Radiat Res. 2010 Jun; 173(6):809-17.
    View in: PubMed
    Score: 0.077
  8. Griffin RJ, Dings RP, Jamshidi-Parsian A, Song CW. Mild temperature hyperthermia and radiation therapy: role of tumour vascular thermotolerance and relevant physiological factors. Int J Hyperthermia. 2010; 26(3):256-63.
    View in: PubMed
    Score: 0.075
  9. Visaria R, Bischof JC, Loren M, Williams B, Ebbini E, Paciotti G, Griffin R. Nanotherapeutics for enhancing thermal therapy of cancer. Int J Hyperthermia. 2007 Sep; 23(6):501-11.
    View in: PubMed
    Score: 0.064
  10. Dings RP, Loren M, Heun H, McNiel E, Griffioen AW, Mayo KH, Griffin RJ. Scheduling of radiation with angiogenesis inhibitors anginex and Avastin improves therapeutic outcome via vessel normalization. Clin Cancer Res. 2007 Jun 01; 13(11):3395-402.
    View in: PubMed
    Score: 0.062
  11. Amano M, Suzuki M, Andoh S, Monzen H, Terai K, Williams B, Song CW, Mayo KH, Hasegawa T, Dings RP, Griffin RJ. Antiangiogenesis therapy using a novel angiogenesis inhibitor, anginex, following radiation causes tumor growth delay. Int J Clin Oncol. 2007 Feb; 12(1):42-7.
    View in: PubMed
    Score: 0.061
  12. Dings RP, Williams BW, Song CW, Griffioen AW, Mayo KH, Griffin RJ. Anginex synergizes with radiation therapy to inhibit tumor growth by radiosensitizing endothelial cells. Int J Cancer. 2005 Jun 10; 115(2):312-9.
    View in: PubMed
    Score: 0.054
  13. Macchi S, Jalihal A, Hooshmand N, Zubair M, Jenkins S, Alwan N, El-Sayed M, Ali N, Griffin RJ, Siraj N. Enhanced photothermal heating and combination therapy of NIR dye via conversion to self-assembled ionic nanomaterials. J Mater Chem B. 2022 02 02; 10(5):806-816.
    View in: PubMed
    Score: 0.043
  14. Shenoi MM, Iltis I, Choi J, Koonce NA, Metzger GJ, Griffin RJ, Bischof JC. Nanoparticle delivered vascular disrupting agents (VDAs): use of TNF-alpha conjugated gold nanoparticles for multimodal cancer therapy. Mol Pharm. 2013 May 06; 10(5):1683-94.
    View in: PubMed
    Score: 0.023
  15. Miller MW, Riedel G, Hoistad D, Sutherland C, Juhn SK, Adams GL, Griffin R, Ondrey FG. Ototoxicity after combined platinum and fractionated radiation in a novel guinea pig model. Am J Otolaryngol. 2009 Jan-Feb; 30(1):1-7.
    View in: PubMed
    Score: 0.017
  16. Park HJ, Choi EK, Choi J, Ahn KJ, Kim EJ, Ji IM, Kook YH, Ahn SD, Williams B, Griffin R, Boothman DA, Lee CK, Song CW. Heat-induced up-regulation of NAD(P)H:quinone oxidoreductase potentiates anticancer effects of beta-lapachone. Clin Cancer Res. 2005 Dec 15; 11(24 Pt 1):8866-71.
    View in: PubMed
    Score: 0.014
  17. Ahn KJ, Lee CK, Choi EK, Griffin R, Song CW, Park HJ. Cytotoxicity of perillyl alcohol against cancer cells is potentiated by hyperthermia. Int J Radiat Oncol Biol Phys. 2003 Nov 01; 57(3):813-9.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.